Ferreira SC, Bruns RE, Ferreira HS, Matos GD, David JM, Brandao GC, da Silva EP, Portugal LA, Dos Reis PS, Souza AS, Dos Santos WN (2007) Box-Behnken design: an alternative for the optimization of analytical methods
No hay evidencias cientficas contundentes (existe mucha controversia) de que la suplementacin con L-Carnitina aumente la oxidacin de cidos grasos
M., Revilla, E., Santa-Maria, C., and Vazquez, C
Research from the American Diabetes Association shows that GLP-1 medications can increase the risk of muscle loss, and patients are often advised to consume more protein to preserve muscle
Risk of hepatic events associated with use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists, and thiazolidinediones among patients with metabolic dysfunction-associated steatotic liver disease